INQR (InnovaQor) Notes Receivable: $0.00 Mil (As of Sep. 2023)


What is InnovaQor Notes Receivable?

InnovaQor INQR -99.80% Notes Receivable is $0.00 Mil as of Sep. 2023.

InnovaQor's Notes Receivable for the quarter that ended in Sep. 2023 was $0.00 Mil.

InnovaQor Notes Receivable Historical Data

* Premium members only.

The historical data trend for InnovaQor's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

InnovaQor Notes Receivable Chart

InnovaQor Annual Data
Trend Jun02 Jun03 Jun04 Jun05 Jun06 Jun07 Dec21 Dec22
Notes Receivable
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

InnovaQor Quarterly Data
Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

InnovaQor Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of $0.00 Mil mean?
InnovaQor (INQR) has a Notes Receivable of $0.00 Mil as of Sep. 2023. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on InnovaQor and its competitors.
Is InnovaQor's Notes Receivable too high?
InnovaQor's current Notes Receivable is $0.00 Mil.
How does InnovaQor's Notes Receivable compare to CBDS and MITI?
InnovaQor's Notes Receivable of $0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Healthcare Providers & Services company?
A good Notes Receivable depends on the Healthcare Providers & Services industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on InnovaQor and its competitors. InnovaQor's current Notes Receivable is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InnovaQor stock overvalued right now?
InnovaQor (INQR) has a current Notes Receivable of $0.00 Mil. The current Notes Receivable is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For InnovaQor (INQR), the current Notes Receivable is $0.00 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

InnovaQor Business Description

Address 477 South Rosemary Avenue, Suite 222, West Palm Beach, FL, USA, 33401
InnovaQor Inc provides information technology solutions and services to healthcare and laboratory customers in the United States. Its goal is to develop and deliver a technology-based medical professional's network communication platform to a broad range of healthcare professionals and businesses using a subscription revenue model with added value bolt-on services.